MEDIUM confidence: 100% data completeness, but the composite (44) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-12.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $225 (last qtr, 10 analysts) → $230 (last mo, 8) (+2.1%).
Buy-rated share 93% → 93% over ~3 months (-0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $-0.10 | $0.47 | +587.8% |
| Jul 2026 | $-0.21 | $-0.14 | +33.5% |
| Apr 2026 | $-0.30 | $-0.18 | +40.0% |
| Feb 2026 | $-0.22 | $-0.28 | -27.3% |
| Oct 2025 | $-0.27 | $-0.16 | +40.7% |
| Jul 2025 | $-0.26 | $-0.24 | +7.7% |
| Apr 2025 | $-0.33 | $-0.22 | +33.3% |
| Feb 2025 | $-0.38 | $-0.40 | -5.3% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $294M— | $283M-3.8% | $315M+11.3% | $383M+21.9% | $507M+32.3% |
| EPS (dil.) | $-1.07— | $-2.09n/m | $-2.78n/m | $-2.77n/m | $-3.28n/m |
| Free Cash Flow | -$23M— | -$63Mn/m | -$78Mn/m | -$68Mn/m | -$54Mn/m |
| Gross Margin | 77.3% | 75.6%-1.7pp | 76.0%+0.4pp | 75.5%-0.5pp | 77.5%+2.0pp |
| Operating Margin | -11.2% | -29.1%-17.9pp | -40.9%-11.8pp | -31.9%+9.0pp | -17.1%+14.8pp |
| Net Margin | -16.9% | -35.1%-18.2pp | -42.8%-7.7pp | -38.2%+4.6pp | -37.0%+1.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider -$24.5M over 180 days (0 open-market buys, 29 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 44 for Glaukos Corporation suggests a neutral outlook, with the stock's short-term score of 52 diverging from its long-term score of 35. The stock scores high on momentum, driven by its 212% return over the past year, but is held back by its low value score due to a high P/S ratio of 20.6 and negative earnings metrics, such as an ROE of -24.9% and a P/E of -81.9, indicating the stock trades at a premium.